Report Detail
Global Influenza Therapeutics Market Size, Status and Forecast 2019-2025
- RnM3809751 |
- 09 October, 2019 |
- Global |
- 90 Pages |
- QYResearch |
- Other
Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.
In 2018, the global Influenza Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Influenza Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Influenza Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Abbott Laboratories
Astrazeneca PLC
Biocryst Pharmaceuticals, Inc.
Chiron Corporation
CSL Limited
Daiichi Sankyo Co., Ltd.
Glaxosmithkline PLC
Mitsubishi Tanabe Pharma Corporation
Nanotherapeutics Inc.
Protein Sciences Corporation
Roche Holding AG
Sanofi SA
Shionogi & Co., Ltd.
Sinovac Biotech Ltd.
Market segment by Type, the product can be split into
Vaccines
Drugs
Market segment by Application, split into
Hospitals
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Influenza Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Influenza Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Influenza Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Influenza Therapeutics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Vaccines
- 1.4.3 Drugs
- 1.5 Market by Application
- 1.5.1 Global Influenza Therapeutics Market Share by Application (2019-2025)
- 1.5.2 Hospitals
- 1.5.3 Clinic
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Influenza Therapeutics Market Size
- 2.2 Influenza Therapeutics Growth Trends by Regions
- 2.2.1 Influenza Therapeutics Market Size by Regions (2019-2025)
- 2.2.2 Influenza Therapeutics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Influenza Therapeutics Market Size by by Players
- 3.1.1 Global Influenza Therapeutics Revenue by by Players (2014-2019)
- 3.1.2 Global Influenza Therapeutics Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Influenza Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Influenza Therapeutics Key Players Head office and Area Served
- 3.3 Key Players Influenza Therapeutics Product/Solution/Service
- 3.4 Date of Enter into Influenza Therapeutics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Influenza Therapeutics Market Size by Type (2014-2019)
- 4.2 Global Influenza Therapeutics Market Size by Application (2014-2019)
5 North America
- 5.1 North America Influenza Therapeutics Market Size (2014-2019)
- 5.2 Influenza Therapeutics Key Players in North America
- 5.3 North America Influenza Therapeutics Market Size by Type
- 5.4 North America Influenza Therapeutics Market Size by Application
6 Europe
- 6.1 Europe Influenza Therapeutics Market Size (2014-2019)
- 6.2 Influenza Therapeutics Key Players in Europe
- 6.3 Europe Influenza Therapeutics Market Size by Type
- 6.4 Europe Influenza Therapeutics Market Size by Application
7 China
- 7.1 China Influenza Therapeutics Market Size (2014-2019)
- 7.2 Influenza Therapeutics Key Players in China
- 7.3 China Influenza Therapeutics Market Size by Type
- 7.4 China Influenza Therapeutics Market Size by Application
8 Japan
- 8.1 Japan Influenza Therapeutics Market Size (2014-2019)
- 8.2 Influenza Therapeutics Key Players in Japan
- 8.3 Japan Influenza Therapeutics Market Size by Type
- 8.4 Japan Influenza Therapeutics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Influenza Therapeutics Market Size (2014-2019)
- 9.2 Influenza Therapeutics Key Players in Southeast Asia
- 9.3 Southeast Asia Influenza Therapeutics Market Size by Type
- 9.4 Southeast Asia Influenza Therapeutics Market Size by Application
10 India
- 10.1 India Influenza Therapeutics Market Size (2014-2019)
- 10.2 Influenza Therapeutics Key Players in India
- 10.3 India Influenza Therapeutics Market Size by Type
- 10.4 India Influenza Therapeutics Market Size by Application
11 Central & South America
- 11.1 Central & South America Influenza Therapeutics Market Size (2014-2019)
- 11.2 Influenza Therapeutics Key Players in Central & South America
- 11.3 Central & South America Influenza Therapeutics Market Size by Type
- 11.4 Central & South America Influenza Therapeutics Market Size by Application
12 International Players Profiles
- 12.1 Abbott Laboratories
- 12.1.1 Abbott Laboratories Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Influenza Therapeutics Introduction
- 12.1.4 Abbott Laboratories Revenue in Influenza Therapeutics Business (2014-2019))
- 12.1.5 Abbott Laboratories Recent Development
- 12.2 Astrazeneca PLC
- 12.2.1 Astrazeneca PLC Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Influenza Therapeutics Introduction
- 12.2.4 Astrazeneca PLC Revenue in Influenza Therapeutics Business (2014-2019)
- 12.2.5 Astrazeneca PLC Recent Development
- 12.3 Biocryst Pharmaceuticals, Inc.
- 12.3.1 Biocryst Pharmaceuticals, Inc. Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Influenza Therapeutics Introduction
- 12.3.4 Biocryst Pharmaceuticals, Inc. Revenue in Influenza Therapeutics Business (2014-2019)
- 12.3.5 Biocryst Pharmaceuticals, Inc. Recent Development
- 12.4 Chiron Corporation
- 12.4.1 Chiron Corporation Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Influenza Therapeutics Introduction
- 12.4.4 Chiron Corporation Revenue in Influenza Therapeutics Business (2014-2019)
- 12.4.5 Chiron Corporation Recent Development
- 12.5 CSL Limited
- 12.5.1 CSL Limited Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Influenza Therapeutics Introduction
- 12.5.4 CSL Limited Revenue in Influenza Therapeutics Business (2014-2019)
- 12.5.5 CSL Limited Recent Development
- 12.6 Daiichi Sankyo Co., Ltd.
- 12.6.1 Daiichi Sankyo Co., Ltd. Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Influenza Therapeutics Introduction
- 12.6.4 Daiichi Sankyo Co., Ltd. Revenue in Influenza Therapeutics Business (2014-2019)
- 12.6.5 Daiichi Sankyo Co., Ltd. Recent Development
- 12.7 Glaxosmithkline PLC
- 12.7.1 Glaxosmithkline PLC Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Influenza Therapeutics Introduction
- 12.7.4 Glaxosmithkline PLC Revenue in Influenza Therapeutics Business (2014-2019)
- 12.7.5 Glaxosmithkline PLC Recent Development
- 12.8 Mitsubishi Tanabe Pharma Corporation
- 12.8.1 Mitsubishi Tanabe Pharma Corporation Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Influenza Therapeutics Introduction
- 12.8.4 Mitsubishi Tanabe Pharma Corporation Revenue in Influenza Therapeutics Business (2014-2019)
- 12.8.5 Mitsubishi Tanabe Pharma Corporation Recent Development
- 12.9 Nanotherapeutics Inc.
- 12.9.1 Nanotherapeutics Inc. Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Influenza Therapeutics Introduction
- 12.9.4 Nanotherapeutics Inc. Revenue in Influenza Therapeutics Business (2014-2019)
- 12.9.5 Nanotherapeutics Inc. Recent Development
- 12.10 Protein Sciences Corporation
- 12.10.1 Protein Sciences Corporation Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Influenza Therapeutics Introduction
- 12.10.4 Protein Sciences Corporation Revenue in Influenza Therapeutics Business (2014-2019)
- 12.10.5 Protein Sciences Corporation Recent Development
- 12.11 Roche Holding AG
- 12.12 Sanofi SA
- 12.13 Shionogi & Co., Ltd.
- 12.14 Sinovac Biotech Ltd.
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Influenza Therapeutics. Industry analysis & Market Report on Influenza Therapeutics is a syndicated market report, published as Global Influenza Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Influenza Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
